Interestingly, we recently reported that post-menopausal women suffering by chronic insomnia, a condition known to be a risk factor for the development of AD [74], display lower levels of FGF21 as compared with age-matched women without sleep disorders [75]. This evidence concerns the gene FGF21 and sleep disorder.